Molecular Partners AG Sponsored ADR (MOLN)
(Delayed Data from NSDQ)
$3.48 USD
-0.46 (-11.68%)
Updated Aug 6, 2025 12:46 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Molecular Partners AG Sponsored ADR has a market cap of $159.08M, which represents its share price of $3.94 multiplied by its outstanding shares number of 40.38M. As a small-cap company, MOLN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MOLN 3.48 -0.46(-11.68%)
Will MOLN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MOLN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MOLN
Here's Why Molecular Partners AG Sponsored ADR (MOLN) Could be Great Choice for a Bottom Fisher
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet
MOLN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MOLN
12 Health Care Stocks Moving In Friday's After-Market Session
UBS AM Acquires Significant Stake in Molecular Partners AG
12 Health Care Stocks Moving In Tuesday's After-Market Session
Molecular Partners’ Promising Oncology Developments and Strategic Focus Earn Buy Rating
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin ...